5th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 23 - April 1, 2024 - Registraiton for on demand access available until April 1!

On demand registration is open until April 1!

Agenda

Our sponsors:
Titanium
Platinum
Gold
Silver

Practical Insights in Novel Immune Therapies in Multiple Myeloma Webinar – West Coast

April 10, 2024 - Webinar

Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this 90-minute webinar is for you!

This high-impact, 90-minute educational program seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.

Tentative Agenda

Our Sponsors

Educational Workshop, Buenos Aires, Argentina

April 19 - 20, 2024 - Sheraton Buenos Aires & Convention Center, Buenos Aires, Argentina

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

Agenda 

Our sponsors:
Silver

2nd Annual Genomics Meeting

July 12 - 13, 2024 - Hilton Barcelona, Barcelona, Spain

The IMS Genomics Meeting was developed in response to the IMS-FDA joint workshop to further consider essential needs in myeloma. The initial invitation-only meeting in 2023 provided an opportunity for myeloma experts from around the world to develop a consensus to define ‘high-risk multiple myeloma’. The publication with the results and recommendations from this meeting has been submitted for review. Building upon this success, the Second IMS Genomics Meeting will be a public meeting led by global myeloma KOL.

In addition to which, this day and a half-long meeting will include sessions on:

  • Risk Stratification validation
  • Genomically targeted therapies
  • New technologies
  • Genomic Biomarkers for stratification of clinical studies
  • New clinical trials for patients with HR disease

21st IMS Annual Meeting

September 25 - 28, 2024 - Rio de Janeiro, Brazil

Mark your calendars for the 21st IMS Annual Meeting in Rio de Janeiro, Brazil!

The 21st IMS Annual Meeting will take place in Rio de Janeiro, Brazil from September 25-28, 2024.

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:

  • Scientific Programs
  • Oral Presentations (on Basic Biology, Preclinical Trials and Clinical Studies)
  • Consensus Panels
  • Poster Presentations

 

Our sponsors:
Titanium
Platinum
Gold

Educational Workshop Johannesburg, South Africa

January 17 - 18, 2025 - Radisson Hotel & Convention Centre, Johannesburg, South Africa

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

6th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 28 - 29, 2025 - Boston Marriott Long Wharf, Boston, MA

IMS is pleased to announce that the 6th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 28-29, 2025 in Boston, MA.

More details will be available soon! 

Educational Workshop Marrakech, Morocco

April 25 - 26, 2025 - Radisson Blu Hotel, Marrakech Carre Eden

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events